jueves, 23 de enero de 2025

RFK Jr., an investor in a CRISPR biotech, has raised alarms about the technology The comments raise a question about how he would regulate gene-editing research as head of HHS

https://www.statnews.com/2025/01/22/rfk-jr-concerns-crispr-how-would-regulate-at-hhs/

No hay comentarios:

Publicar un comentario